AIM Banners_978 x 90

Second-generation AI-powered digital pills are changing the future of healthcare

The Second-generation AI systems focus on progress where rather than analysing data for diagnosis assistance, prediction, or tailoring therapy, the second-generation platforms help in improving the biological processes.
Improving global health requires drugs to be more effective and affordable. While there are multiple branded and generic drugs available, partial or complete loss of response to chronic medications is a major cause that leads to ineffectiveness. Combining this with a lack of adherence by patients leads to even more healthcare issues.   The first-generation AI systems did not address these needs, which led to a low adoption rate. But the second-generation AI systems are focused on a single subject – improving patients' clinical outcomes. The digital pills combine a personalised second-generation AI system along with the branded or generic drug and improve the patient response as it increases adherence and overcomes the loss of response to chronic medications. It works on impr
Subscribe or log in to Continue Reading

Uncompromising innovation. Timeless influence. Your support powers the future of independent tech journalism.

Already have an account? Sign In.

📣 Want to advertise in AIM? Book here

Picture of Meeta Ramnani
Meeta Ramnani
Meeta’s interest lies in finding out real practical applications of technology. At AIM, she writes stories that question the new inventions and the need to develop them. She believes that technology has and will continue to change the world very fast and that it is no more ‘cool’ to be ‘old-school’. If people don’t update themselves with the technology, they will surely be left behind.
Related Posts
AIM Print and TV
Don’t Miss the Next Big Shift in AI.
Get one year subscription for ₹5999
Download the easiest way to
stay informed